Total Parenteral Nutrition (TPN) or Hyperalimentation 11.01.04
Summary
Excellus BlueCross BlueShield policy 11.01.04 considers total parenteral nutrition (TPN) medically appropriate for malnourished individuals with listed conditions, including short bowel syndrome, Crohn's disease, cystic fibrosis with malnutrition unresponsive to enteral nutrition, and adult acute necrotizing pancreatitis with inadequate oral intake for longer than a week. Home TPN for intractable hyperemesis gravidarum is considered medically appropriate only when all listed criteria are met, and intradialytic parenteral or intraperitoneal nutrition for end-stage renal disease is considered medically appropriate only as an alternative to regularly scheduled TPN and as an incremental boost in calories. TPN is considered not medically necessary for advanced cancer unresponsive to chemotherapy or radiation, for children who were well-nourished or mildly malnourished undergoing low nutrition-risk oncologic treatment, and for individuals for whom liver transplantation is not feasible and whose prognosis will not change with TPN. The version effective February 19, 2026 is an annual review with policy intent unchanged.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.